Profile of brivaracetam and its potential in the treatment of epilepsy

Brivaracetam (BRV) (UCB 34714) is currently under review by the US Food and Drug Administration and European Medicines Agency for approval as an add-on treatment for adult patients with partial seizures. Similar to levetiracetam (LEV), BRV acts as a high-affinity ligand of the synaptic vesicle prote...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuropsychiatr Dis Treat
Main Authors: Ferlazzo, Edoardo, Russo, Emilio, Mumoli, Laura, Sueri, Chiara, Gasparini, Sara, Palleria, Caterina, Labate, Angelo, Gambardella, Antonio, De Sarro, Giovambattista, Aguglia, Umberto
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2015
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4670022/
https://ncbi.nlm.nih.gov/pubmed/26664121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S60849
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados